Chandra Asri Petrochemical Tbk PT (PTCAY) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Chandra Asri Petrochemical Tbk PT $4.83, price $8.00, upside -39.6%, quality 50 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Chandra Asri Petrochemical Tbk PT ADR for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.
How to read this chart
60‑month range $0.9602 – $61.05 · fair‑value band $3.39 – $13.53 · the $8.00 price screens above the $4.83 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Sep 24, 2026.
Follow Chandra Asri Petrochemical Tbk PT ADR in your weekly email
Every Wednesday you see whether Chandra Asri Petrochemical Tbk PT ADR is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
PT Chandra Asri Pacific Tbk provides chemical and infrastructure solutions in Indonesia and Singapore. It operates through Energy, Chemical, and Infrastructure segments. The company offers olefins, such as ethylene, propylene, pyrolysis gasoline, crude C4, and pyrolysis fuel oil.
Show more
PT Chandra Asri Pacific Tbk provides chemical and infrastructure solutions in Indonesia and Singapore. It operates through Energy, Chemical, and Infrastructure segments. The company offers olefins, such as ethylene, propylene, pyrolysis gasoline, crude C4, and pyrolysis fuel oil. It also provides polyolefins comprising polyethylene products, including linear low density and high-density polyethylene under the Asrene brand name; and polypropylene products, such as homopolymer, random and impact copolymer, and terpolymer under the Trilene brand name for use in food packaging, housewares, electronics, and automotive products. The company offers styrene monomer, an organic monomer aromatics compound for use in the production of polystyrene, expanded polystyrene, styrene acrylonitrile, acrylonitrile butadiene styrene, styrene butadiene rubber, styrene butadiene latex, and unsaturated polyester resin; butadiene, a conjugated diene to produce styrene-butadiene rubber, adhesives, sealants, coatings, and other rubber products; and raffinate-1 and chlor alkali products. It also engages in the sale of electricity and other electrical services, as well as fuels; wholesale business; leasing of tanks and jetty; and management consulting, warehousing, storage, water treatment, and seaport services. The company offers ethylene dichloride, a chemical input to produce polyvinyl chloride; butene-1, an organic chemical used as a co-monomer of polyethylene polymerization; methyl tert-butyl ether (MTBE), a volatile organic compound; and raffinate-2, a by-product of MTBE used as feedstock. It also exports its products. The company was formerly known as PT Chandra Asri Petrochemical Tbk and changed its name to PT Chandra Asri Pacific Tbk in January 2024. The company was founded in 1984 and is headquartered in Jakarta, Indonesia.
Stock analysis
Chandra Asri Petrochemical Tbk PT ADR (PTCAY) currently trades at $8.00, while our model-based Fair Value estimate is $4.83, implying the stock looks roughly 65.5% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of $29.73 per share, and 9 of the 12 models we run sit above the $8.00 price.
Bear case: the Dividend Discount group reads lowest at $0.8700, and 3 of the 12 models stay below the price. Evidence for this calculation is medium.
Scenario range: $3.39 (bear) to $13.53 (bull), the price of $8.00 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Basic Materials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Chandra Asri Petrochemical Tbk PT ADR reported revenue of $7.0B in FY2025 versus $2.6B in FY2021, a compound +28.4%/yr. Reported net income was $1.1B in FY2025, compounding +63.6%/yr from FY2021.
Key figures
Market cap $7.1B · P/E ratio 3.8 · P/S ratio 0.59 · EPS (TTM) $2.10 · Dividend yield 1.2% · Net margin 15.5% · Return on equity 42.4% · Return on assets (EBIT) −0.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (medium confidence).
What moves the price
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −40%, PTCAY screens cheaper than that median.
Fair Value models
Bear $3.39Fair Value $4.83Bull $13.53
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($1.54 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.60/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+293.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+43.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.2%
Start year 2020 (pandemic). Over 10 years: +17.7% a year
Revenue growth 31 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.8%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+89.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+88.0%
Dividend (yield on the price)1.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.88% vs 46%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → −8%
Compare Chandra Asri Petrochemical Tbk PT ADR with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score50 · Below median
Fair Value upside−40% · Below median
Profitability
Return on equity (TTM)42% · Top 25%
Return on assets−1% · Bottom 25%
Net margin (TTM)14% · Top 25%
Operating margin (TTM)16% · Top 25%
Growth and dividend
Revenue growth286% · Top 25%
Dividend yield (TTM)1.2% · Below median
Balance sheet
Debt / equity1.19× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)3.8× · Cheapest 25%
P/B1.90× · Pricier than median
P/S (TTM)0.80× · Cheaper than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 21
PAST (return on equity)100· sector 23
HEALTH (low debt)40· sector 95
DIVIDEND (yield)23· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Chandra Asri Petrochemical Tbk PT (PTCAY) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $4.83 versus a price of $8.00, about −40% upside (overvalued).
What is the fair value of PTCAY?
Our model-based fair value for Chandra Asri Petrochemical Tbk PT ADR is $4.83 (as of Sep 24, 2026), built from audited fundamentals. The current price: $8.00.
What is the quality score of PTCAY?
Chandra Asri Petrochemical Tbk PT ADR has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Chandra Asri Petrochemical Tbk PT (PTCAY)?
Our model-based price target is the fair value of $4.83 (as of Sep 24, 2026) from 12 valuation models. Cautious scenario $3.39, optimistic scenario $13.53. It is a calculation from audited fundamentals, not an analyst target.
What is the Chandra Asri Petrochemical Tbk PT ADR stock forecast for 2026?
Our models put fair value at $4.83, about −40% upside versus a price of $8.00 (overvalued). Cautious scenario $3.39, optimistic scenario $13.53. The calculation is refreshed regularly with new filings.
What is the revenue of Chandra Asri Petrochemical Tbk PT (PTCAY)?
Chandra Asri Petrochemical Tbk PT ADR reported trailing-twelve-month revenue of about $8.8B (latest available figure, as of Sep 24, 2026).
Does Chandra Asri Petrochemical Tbk PT ADR pay a dividend?
Chandra Asri Petrochemical Tbk PT ADR currently shows a dividend yield of about 1.15% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Chandra Asri Petrochemical Tbk PT (PTCAY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Chandra Asri Petrochemical Tbk PT ADR it is $4.83 per share (as of Sep 24, 2026), against a price of $8.00. It is the blended result of 12 valuation models (cash flow, earnings, asset, dividend).
Is Chandra Asri Petrochemical Tbk PT ADR stock overvalued or undervalued in 2026?
As of Sep 24, 2026, PTCAY trades above its calculated fair value: price $8.00, fair value $4.83, a gap of about −40% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PTCAY?
No. The price is what the market pays today ($8.00); the fair value is what the company's own numbers justify ($4.83). For Chandra Asri Petrochemical Tbk PT ADR the two are $3.17 per share apart. That gap is exactly why we show both numbers side by side.
How much is Chandra Asri Petrochemical Tbk PT ADR worth?
The market values Chandra Asri Petrochemical Tbk PT ADR at about $7.1B (market capitalisation, as of Sep 24, 2026). Per share that is $8.00; our models calculate a fair value of $4.83 per share.
What do the bullish and bearish scenarios say about PTCAY?
Our models span a range for Chandra Asri Petrochemical Tbk PT ADR: cautious scenario $3.39, base $4.83, optimistic $13.53 per share (as of Sep 24, 2026, price $8.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of PTCAY?
Chandra Asri Petrochemical Tbk PT ADR trades at a price-to-earnings ratio of 3.8 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $4.83 is built from several models across several years. Other multiples: P/B 1.9, P/S 0.8.
How solid is the balance sheet of Chandra Asri Petrochemical Tbk PT (PTCAY)?
Balance-sheet figures for Chandra Asri Petrochemical Tbk PT ADR (as of Sep 24, 2026): return on equity 42.4%, debt of 1.19 per unit of equity. They feed the Quality Score of 50/100, which measures business quality independently of the share price.
Which stocks are comparable to Chandra Asri Petrochemical Tbk PT ADR?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Chandra Asri Petrochemical Tbk PT ADR stock attractive at the current price?
The data as of Sep 24, 2026: price $8.00, calculated fair value $4.83 (−40%), Quality Score 50/100, from 12 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PTCAY calculated?
We run Chandra Asri Petrochemical Tbk PT ADR through 12 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $4.83, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Chandra Asri Petrochemical Tbk PT ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The closing price on Sep 23, 2026 was $8.00. Our model-based fair value is $4.83, about −40% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Chandra Asri Petrochemical Tbk PT ADR right now?
The model range is unusually wide ($3.39 to $13.53). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (50/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of Chandra Asri Petrochemical Tbk PT ADR
How large is the market capitalisation of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The market capitalisation of Chandra Asri Petrochemical Tbk PT ADR is $7.1B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The price-to-sales ratio of Chandra Asri Petrochemical Tbk PT ADR is 0.59 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Chandra Asri Petrochemical Tbk PT (PTCAY)?
Earnings per share at Chandra Asri Petrochemical Tbk PT ADR are $2.10 (price ÷ EPS = P/E 3.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The dividend yield of Chandra Asri Petrochemical Tbk PT ADR is 1.2% (payout 4.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The net margin of Chandra Asri Petrochemical Tbk PT ADR is 15.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The return on equity (ROE) of Chandra Asri Petrochemical Tbk PT ADR is 42.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Chandra Asri Petrochemical Tbk PT (PTCAY)?
On an EBIT basis the return on assets of Chandra Asri Petrochemical Tbk PT ADR is −0.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Chandra Asri Petrochemical Tbk PT (PTCAY)?
The operating margin of Chandra Asri Petrochemical Tbk PT ADR is 16.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Chandra Asri Petrochemical Tbk PT (PTCAY)?
Revenue at Chandra Asri Petrochemical Tbk PT ADR is growing +286% versus a year earlier (3y avg +43.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Chandra Asri Petrochemical Tbk PT (PTCAY)?
Earnings per share at Chandra Asri Petrochemical Tbk PT ADR are growing −97.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Chandra Asri Petrochemical Tbk PT (PTCAY) generate?
The free cash flow of Chandra Asri Petrochemical Tbk PT ADR is −$387M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Chandra Asri Petrochemical Tbk PT (PTCAY) carry?
The net debt of Chandra Asri Petrochemical Tbk PT ADR is $2.7B (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Chandra Asri Petrochemical Tbk PT ADR in the live analysis
One click puts Chandra Asri Petrochemical Tbk PT ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 24, 2026